NICE Guidance on Mirvetuximab Ovarian Cancer Tr...

By HEOR Staff Writer

June 5, 2026

Mirvetuximab ovarian cancer treatment has taken a major step forward after NICE recommended mirvetuximab soravtansine for adults with folate receptor-alpha positive, platinum-resistant high-grade serous epithelial ovarian, fallopian tube or primar...